未经治疗的门诊患者隐匿性高血压亚型和靶器官损害。

IF 2.3 4区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Blood Pressure Pub Date : 2020-10-01 Epub Date: 2020-05-13 DOI:10.1080/08037051.2020.1763159
Dong-Yan Zhang, Yi-Bang Cheng, Qian-Hui Guo, Ying Wang, Chang-Sheng Sheng, Qi-Fang Huang, De-Wei An, Ming-Xuan Li, Jian-Feng Huang, Ting-Yan Xu, Ji-Guang Wang, Yan Li
{"title":"未经治疗的门诊患者隐匿性高血压亚型和靶器官损害。","authors":"Dong-Yan Zhang,&nbsp;Yi-Bang Cheng,&nbsp;Qian-Hui Guo,&nbsp;Ying Wang,&nbsp;Chang-Sheng Sheng,&nbsp;Qi-Fang Huang,&nbsp;De-Wei An,&nbsp;Ming-Xuan Li,&nbsp;Jian-Feng Huang,&nbsp;Ting-Yan Xu,&nbsp;Ji-Guang Wang,&nbsp;Yan Li","doi":"10.1080/08037051.2020.1763159","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> Masked hypertension (MHT) is characterised as an office normotension in the presence of out-of-office hypertension, and can be further categorised as isolated daytime (dMHT), night-time (nMHT) or day-night MHT (dnMHT) according to the time when hypertension is present. MHT is associated with adverse cardiovascular outcome. However, no previous studies contrasted these MHT subtypes in their associations with target organ damage (TOD).<b>Materials and methods:</b> Consecutive untreated patients referred for ambulatory blood pressure (BP) monitoring to our Hypertension Clinic were recruited. Office and ambulatory BPs were measured using the Omron 7051 and SpaceLabs 90217 monitors, respectively. The BP thresholds of daytime and night-time hypertension were of ≥135/85 mmHg and ≥120/70 mmHg, respectively. We performed various TOD measurements, including carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (cIMT), left ventricular mass index (LVMI) and E/E', estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR).<b>Results:</b> The 1808 participants (mean age, 51 years; women, 52%) included 672 (37.2%) MHT subjects, among whom 123 (18.3%) had dMHT, 78 (11.6%) nMHT, and 471 (70.1%) dnMHT. In all participants as well as patients with office normotension (<i>n</i> = 1222), ambulatory daytime and night-time BPs were similarly associated with all TOD measurements (<i>p</i> ≥ 0.20) after multivariate adjustment. Compared to normotensive subjects (<i>p</i> < 0.05), patients with dMHT had faster cfPWV (7.81 vs. 7.58 m/s) and thicker cIMT (637.6 vs. 610.4 µm), patients with nMHT had thicker cIMT (641.8 vs. 610.4 µm) and increased UACR (0.79 vs. 0.59 mg/mmol), and patients with dnMHT had all worse TOD measures mentioned-above plus elevated eGFR (120.7 vs. 116.8 ml/min/1.73m<sup>2</sup>).<b>Conclusion:</b> MHT was associated with TOD irrespective of subtype, although TOD varied slightly across these subtypes. The study highlights the importance of controlling both daytime and night-time BP in hypertensive patients.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1763159","citationCount":"7","resultStr":"{\"title\":\"Subtypes of masked hypertension and target organ damage in untreated outpatients.\",\"authors\":\"Dong-Yan Zhang,&nbsp;Yi-Bang Cheng,&nbsp;Qian-Hui Guo,&nbsp;Ying Wang,&nbsp;Chang-Sheng Sheng,&nbsp;Qi-Fang Huang,&nbsp;De-Wei An,&nbsp;Ming-Xuan Li,&nbsp;Jian-Feng Huang,&nbsp;Ting-Yan Xu,&nbsp;Ji-Guang Wang,&nbsp;Yan Li\",\"doi\":\"10.1080/08037051.2020.1763159\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> Masked hypertension (MHT) is characterised as an office normotension in the presence of out-of-office hypertension, and can be further categorised as isolated daytime (dMHT), night-time (nMHT) or day-night MHT (dnMHT) according to the time when hypertension is present. MHT is associated with adverse cardiovascular outcome. However, no previous studies contrasted these MHT subtypes in their associations with target organ damage (TOD).<b>Materials and methods:</b> Consecutive untreated patients referred for ambulatory blood pressure (BP) monitoring to our Hypertension Clinic were recruited. Office and ambulatory BPs were measured using the Omron 7051 and SpaceLabs 90217 monitors, respectively. The BP thresholds of daytime and night-time hypertension were of ≥135/85 mmHg and ≥120/70 mmHg, respectively. We performed various TOD measurements, including carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (cIMT), left ventricular mass index (LVMI) and E/E', estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR).<b>Results:</b> The 1808 participants (mean age, 51 years; women, 52%) included 672 (37.2%) MHT subjects, among whom 123 (18.3%) had dMHT, 78 (11.6%) nMHT, and 471 (70.1%) dnMHT. In all participants as well as patients with office normotension (<i>n</i> = 1222), ambulatory daytime and night-time BPs were similarly associated with all TOD measurements (<i>p</i> ≥ 0.20) after multivariate adjustment. Compared to normotensive subjects (<i>p</i> < 0.05), patients with dMHT had faster cfPWV (7.81 vs. 7.58 m/s) and thicker cIMT (637.6 vs. 610.4 µm), patients with nMHT had thicker cIMT (641.8 vs. 610.4 µm) and increased UACR (0.79 vs. 0.59 mg/mmol), and patients with dnMHT had all worse TOD measures mentioned-above plus elevated eGFR (120.7 vs. 116.8 ml/min/1.73m<sup>2</sup>).<b>Conclusion:</b> MHT was associated with TOD irrespective of subtype, although TOD varied slightly across these subtypes. The study highlights the importance of controlling both daytime and night-time BP in hypertensive patients.</p>\",\"PeriodicalId\":55591,\"journal\":{\"name\":\"Blood Pressure\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2020-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/08037051.2020.1763159\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Pressure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08037051.2020.1763159\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/5/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Pressure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08037051.2020.1763159","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/5/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 7

摘要

目的:隐蔽性高血压(MHT)的特征是在办公室外高血压存在的情况下出现办公室正常血压,根据高血压出现的时间可进一步分为孤立性白天(dMHT)、夜间(nMHT)或昼夜MHT (dnMHT)。MHT与不良心血管结局相关。然而,之前没有研究对比这些MHT亚型与靶器官损伤(TOD)的关系。材料和方法:招募连续未治疗的患者到我们的高血压门诊进行动态血压监测。分别使用欧姆龙7051和SpaceLabs 90217监测器测量办公室和活动时的血压。白天和夜间高血压血压阈值分别为≥135/85 mmHg和≥120/70 mmHg。我们进行了各种TOD测量,包括颈动脉-股动脉脉搏波速度(cfPWV)、颈动脉内膜-中膜厚度(cIMT)、左心室质量指数(LVMI)和E/E′、肾小球滤过率(eGFR)和尿白蛋白-肌酐比(UACR)。结果:1808名参与者(平均年龄51岁;女性(52%)包括672例(37.2%)MHT患者,其中123例(18.3%)患有dMHT, 78例(11.6%)患有nMHT, 471例(70.1%)患有dnMHT。在所有参与者以及办公室血压正常的患者(n = 1222)中,多因素调整后,日间和夜间的动态血压与所有TOD测量值相似(p≥0.20)。与血压正常者比较(p 2)。结论:MHT与TOD无关,尽管TOD在这些亚型中略有不同。该研究强调了控制高血压患者白天和夜间血压的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Subtypes of masked hypertension and target organ damage in untreated outpatients.

Purpose: Masked hypertension (MHT) is characterised as an office normotension in the presence of out-of-office hypertension, and can be further categorised as isolated daytime (dMHT), night-time (nMHT) or day-night MHT (dnMHT) according to the time when hypertension is present. MHT is associated with adverse cardiovascular outcome. However, no previous studies contrasted these MHT subtypes in their associations with target organ damage (TOD).Materials and methods: Consecutive untreated patients referred for ambulatory blood pressure (BP) monitoring to our Hypertension Clinic were recruited. Office and ambulatory BPs were measured using the Omron 7051 and SpaceLabs 90217 monitors, respectively. The BP thresholds of daytime and night-time hypertension were of ≥135/85 mmHg and ≥120/70 mmHg, respectively. We performed various TOD measurements, including carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (cIMT), left ventricular mass index (LVMI) and E/E', estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR).Results: The 1808 participants (mean age, 51 years; women, 52%) included 672 (37.2%) MHT subjects, among whom 123 (18.3%) had dMHT, 78 (11.6%) nMHT, and 471 (70.1%) dnMHT. In all participants as well as patients with office normotension (n = 1222), ambulatory daytime and night-time BPs were similarly associated with all TOD measurements (p ≥ 0.20) after multivariate adjustment. Compared to normotensive subjects (p < 0.05), patients with dMHT had faster cfPWV (7.81 vs. 7.58 m/s) and thicker cIMT (637.6 vs. 610.4 µm), patients with nMHT had thicker cIMT (641.8 vs. 610.4 µm) and increased UACR (0.79 vs. 0.59 mg/mmol), and patients with dnMHT had all worse TOD measures mentioned-above plus elevated eGFR (120.7 vs. 116.8 ml/min/1.73m2).Conclusion: MHT was associated with TOD irrespective of subtype, although TOD varied slightly across these subtypes. The study highlights the importance of controlling both daytime and night-time BP in hypertensive patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Blood Pressure
Blood Pressure 医学-外周血管病
CiteScore
3.00
自引率
5.60%
发文量
41
审稿时长
6-12 weeks
期刊介绍: For outstanding coverage of the latest advances in hypertension research, turn to Blood Pressure, a primary source for authoritative and timely information on all aspects of hypertension research and management. Features include: • Physiology and pathophysiology of blood pressure regulation • Primary and secondary hypertension • Cerebrovascular and cardiovascular complications of hypertension • Detection, treatment and follow-up of hypertension • Non pharmacological and pharmacological management • Large outcome trials in hypertension.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信